Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04BQR
|
||||
| Former ID |
DIB003267
|
||||
| Drug Name |
Acecainide
|
||||
| Synonyms |
NAPA; Acecainide hydrochloride; ASL-601
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Discontinued in Phase 3 | [544619] | ||
| Company |
King Pharmaceuticals R&D Inc
|
||||
| Formula |
C15H23N3O2
|
||||
| Canonical SMILES |
C(=O)(c1ccc(NC(=O)C)cc1)NCCN(CC)CC
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Potassium channel | Target Info | Opener | [528400] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.